LEADER 04563nam  2201045z- 450 
001 9910566473203321
005 20231214132935.0
035   $a(CKB)5680000000037648
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81044
035   $a(EXLCZ)995680000000037648
100   $a20202205d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAntimicrobial Resistance and Virulence - 2nd Volume
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (156 p.)
311   $a3-0365-3908-5 
311   $a3-0365-3907-7 
330   $aThe worldwide dissemination of antimicrobial-resistant bacteria, particularly those resistant to last-resource antibiotics, is a common problem to which no immediate solution is foreseen. In 2017, the World Health Organization (WHO) published a list of antimicrobial-resistant "priority pathogens", which include a group of microorganisms with high-level resistance to multiple drugs, named ESKAPE pathogens, comprising vancomycin-resistant Enterococcus faecium (VRE), methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA), extended spectrum ?-lactamase (ESBL) or carbapenem-resistant Klebsiella pneumoniae, carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa and extended spectrum ?-lactamase (ESBL) or carbapenem-resistant Enterobacter spp. These bacteria also have the ability to produce several virulence factors, which have a major influence on the outcomes of infectious diseases. Bacterial resistance and virulence are interrelated, since antibiotics pressure may influence bacterial virulence gene expression and, consequently, infection pathogenesis. Additionally, some virulence factors contribute to an increased resistance ability, as observed in biofilm-producing strains. The surveillance of important resistant and virulent clones and associated mobile genetic elements is essential to decision making in terms of mitigation measures to be applied for the prevention of such infections in both human and veterinary medicine, being also relevant to address the role of natural environments as important components of the dissemination cycle of these strains.
606   $aResearch & information: general$2bicssc
606   $aBiology, life sciences$2bicssc
606   $aMicrobiology (non-medical)$2bicssc
610   $abiocide
610   $aantibiotic resistance
610   $across-resistance
610   $aaminoglycoside
610   $aadaptation
610   $abiofilm
610   $apyruvate cycle
610   $amastitis
610   $astaphylococci
610   $avirulence factors
610   $agenes
610   $aantimicrobial resistance
610   $ainfant
610   $anewborn
610   $abacteremia
610   $aGram-negative bacteria
610   $adrug resistance
610   $amicrobial
610   $amortality
610   $amicrocosm
610   $aAeromonas
610   $aclimate change
610   $atemperature
610   $apH
610   $awater
610   $aAcinetobacter baumannii
610   $avirulence
610   $awhole-genome sequencing
610   $ainternational high-risk clones
610   $agenomic epidemiology
610   $adogs
610   $aEscherichia coli
610   $aESBL
610   $aCTX-M-15
610   $aCTX-M-1
610   $aCTX-M-32
610   $aCTX-M-55
610   $aCTX-M-14
610   $aqAmpC
610   $aCMY-2
610   $acamel
610   $adomestic
610   $amilk
610   $avirulence genes
610   $aextended-spectrum ?-lactamases
610   $abiofilm formation
610   $aPseudomonas aeruginosa
610   $acarbapenem resistance
610   $aKPC-2
610   $aplasmid
610   $adiabetic foot infections
610   $aStaphylococcus aureus
610   $asubinhibitory concentrations
610   $avirulence-related genes
615  7$aResearch & information: general
615  7$aBiology, life sciences
615  7$aMicrobiology (non-medical)
700   $aOliveira$b Manuela$4edt$01314106
702   $aSilva$b Elisabete$4edt
702   $aOliveira$b Manuela$4oth
702   $aSilva$b Elisabete$4oth
906   $aBOOK
912   $a9910566473203321
996   $aAntimicrobial Resistance and Virulence - 2nd Volume$93031713
997   $aUNINA